NURS 6521APPROACHES TO HEALTH FINAL
EXAM QUESTIONS WITH CORRECT
DETAILED SOLUTIONS NEWLY MODIFIED
• Question 11
1 out of 1 points
A young patient is prescribed Vyvanse. During the follow-up appointment,
which comment made by the patient makes the PMHNP think that the dosing is
being done incorrectly?
Selected B.
Answer: “I am unable to fall asleep
at night.”
• Question 12
1 out of 1 points
A 14-year-old patient is prescribed Strattera and asks when the medicine should
be taken. What does the PMHNP understand regarding the drug’s dosing
profile?
Page 1 of 35
, Selected B.
Answer: The patient will have one or two doses a day.
• Question 13
0 out of 1 points
The PMHNP is meeting with the parents of an 8-year-old patient who is
receiving an initial prescription for D-amphetamine. The PMHNP demonstrates
appropriate prescribing practices when she prescribes the following dose:
Selected D.
Answer: The child will take 10–40 mg, daily.
• Question 14
1 out of 1 points
A patient is being prescribed bupropion and is concerned about the side effects.
What will the PMHNP tell the patient regarding bupropion?
Selected C.
Answer: It can cause cardiac
arrhythmias.
• Question 15
Page 2 of 35
, 1 out of 1 points
Which patient will receive a lower dose of guanfacine?
Selected D.
Answer: Patient with kidney disease
• Question 16
1 out of 1 points
An 18-year-old female with a history of frequent headaches and a mood
disorder is prescribed topiramate (Topamax), 25 mg by mouth daily. The
PMHNP understands that this medication is effective in treating which
condition(s) in this patient?
Selected A.
Answer: Migrain
es
• Question 17
1 out of 1 points
The PMHNP is treating a patient for fibromyalgia and is considering
prescribing milnacipran (Savella). When prescribing this medication, which
action is the PMHNP likely to choose?
Selected C.
Page 3 of 35
, Answer: Split the daily dose into two doses after the first day.
18
The PMHNP is assessing a patient she has been treating with the diagnosis of
chronic pain. During the assessment, the patient states that he has recently been
having trouble getting to sleep and staying asleep. Based on this information,
what action is the PMHNP most likely to take?
Selected A.
Answer: Order hydroxyzine (Vistaril), 50 mg PRN or as needed
• Question 19
1 out of 1 points
The PMHNP is assessing a female patient who has been taking lamotrigine
(Lamictal) for migraine prophylaxis. After discovering that the patient has
reached the maximum dose of this medication, the PMHNP decides to change
the patient’s medication to zonisamide
(Zonegran). In addition to evaluating this patient’s day-to-day activities, what
should the PMHNP ensure that this patient understands?
Selected D.
Answer: This medication has unwanted side effects such as sedation, lack of
coordination, and drowsiness.
• Question 20
Page 4 of 35
EXAM QUESTIONS WITH CORRECT
DETAILED SOLUTIONS NEWLY MODIFIED
• Question 11
1 out of 1 points
A young patient is prescribed Vyvanse. During the follow-up appointment,
which comment made by the patient makes the PMHNP think that the dosing is
being done incorrectly?
Selected B.
Answer: “I am unable to fall asleep
at night.”
• Question 12
1 out of 1 points
A 14-year-old patient is prescribed Strattera and asks when the medicine should
be taken. What does the PMHNP understand regarding the drug’s dosing
profile?
Page 1 of 35
, Selected B.
Answer: The patient will have one or two doses a day.
• Question 13
0 out of 1 points
The PMHNP is meeting with the parents of an 8-year-old patient who is
receiving an initial prescription for D-amphetamine. The PMHNP demonstrates
appropriate prescribing practices when she prescribes the following dose:
Selected D.
Answer: The child will take 10–40 mg, daily.
• Question 14
1 out of 1 points
A patient is being prescribed bupropion and is concerned about the side effects.
What will the PMHNP tell the patient regarding bupropion?
Selected C.
Answer: It can cause cardiac
arrhythmias.
• Question 15
Page 2 of 35
, 1 out of 1 points
Which patient will receive a lower dose of guanfacine?
Selected D.
Answer: Patient with kidney disease
• Question 16
1 out of 1 points
An 18-year-old female with a history of frequent headaches and a mood
disorder is prescribed topiramate (Topamax), 25 mg by mouth daily. The
PMHNP understands that this medication is effective in treating which
condition(s) in this patient?
Selected A.
Answer: Migrain
es
• Question 17
1 out of 1 points
The PMHNP is treating a patient for fibromyalgia and is considering
prescribing milnacipran (Savella). When prescribing this medication, which
action is the PMHNP likely to choose?
Selected C.
Page 3 of 35
, Answer: Split the daily dose into two doses after the first day.
18
The PMHNP is assessing a patient she has been treating with the diagnosis of
chronic pain. During the assessment, the patient states that he has recently been
having trouble getting to sleep and staying asleep. Based on this information,
what action is the PMHNP most likely to take?
Selected A.
Answer: Order hydroxyzine (Vistaril), 50 mg PRN or as needed
• Question 19
1 out of 1 points
The PMHNP is assessing a female patient who has been taking lamotrigine
(Lamictal) for migraine prophylaxis. After discovering that the patient has
reached the maximum dose of this medication, the PMHNP decides to change
the patient’s medication to zonisamide
(Zonegran). In addition to evaluating this patient’s day-to-day activities, what
should the PMHNP ensure that this patient understands?
Selected D.
Answer: This medication has unwanted side effects such as sedation, lack of
coordination, and drowsiness.
• Question 20
Page 4 of 35
